Form 4: Guided Therapeutics Director Acquires Shares Through Dividend Conversion

John E. Imhoff, a director and 10% owner of Guided Therapeutics, acquired 36,161 shares of common stock through the conversion of accrued dividends on Series D preferred stock.

Summary

• On October 15, 2024, John E. Imhoff, a director and 10% owner of Guided Therapeutics Inc. (GTHP), acquired 36,161 shares of common stock.
• The acquisition was a result of the payment of accrued dividends on Imhoff's Series D preferred stock.
• The conversion price for the dividend payment was $0.1556 per share.
• Following the transaction, Imhoff directly owns 7,112,059 shares of Guided Therapeutics common stock.

Sentiment

Score: 5

Explanation: The document is a routine regulatory filing detailing an insider transaction. It doesn't inherently convey positive or negative sentiment, but rather reports a factual event.

Industry Context

This filing reflects insider activity related to dividend payments and stock ownership, which is a common occurrence in publicly traded companies. The conversion of preferred stock dividends into common stock is a mechanism for distributing value to preferred shareholders.

Stakeholder Impact

• The transaction increases the number of outstanding common shares, which could potentially dilute existing shareholders' ownership.

Key Dates

Keywords

Guided Therapeutics, GTHP, John E. Imhoff, Form 4, Beneficial Ownership, Dividend Conversion, Series D Preferred Stock, Director, 10% Owner